EFFICACY AND SAFETY OF GUSELKUMAB TN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS WHO DEMONSTRATED INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITION: WEEK 24 RESULTS OF A PHASE 3B, RANDOMIZED, CONTROLLED STUDY

被引：0

作者：

Coates, Laura C. ^{[1
]}

Gossec, Laure ^{[2
]}

Theander, Elke ^{[3
]}

Bergmans, Paul ^{[4
]}

Neuhold, Marlies ^{[5
]}

Karyekar, Chetan S. ^{[6
]}

Shawi, May ^{[6
]}

Noel, Wim ^{[5
]}

Schett, Georg ^{[7
]}

McInnes, Iain B. ^{[8
]}

机构：

[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[2] Sorbonne Univ, Dept Rheumatol, Paris, France

[3] Janssen Sci Affairs LLC, Dept Immunol, Solna, Sweden

[4] Janssen, Dept Biostat, Breda, Netherlands

[5] Janssen Sci Affairs LLC, Dept Immunol, Brussels, Belgium

[6] Janssen Global Serv LLC, Dept Immunol, Horsham, PA USA

[7] FAU Erlangen Nurnberg, Dept Internal Med 3, Nurnberg, Germany

[8] Univ Glasgow, Dept Immunol, Glasgow, Lanark, Scotland

来源：

关键词：

DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PANLAR2021

引用

页码：S106 / S107

页数：2

共 2 条